Kerala

Financial BO

Goods

Medicines

Re-tender for the procurement Anti cancer drugs for the year 2026-27

Kerala Medical Services Corporation Ltd

Thiruvananthapuram, Kerala

Amount: Refer DocsCloses: 18 May 202611 May 2026

Corrigendum

Closed

Bids

Item Wise

3 Bids11 Jun 2026

#	Company	Amount	Rank	Status
1	L1₹75.90Admitted-Finance NA \| NA \| NA \| 121004	₹75.90	L1	Admitted-Finance
2	L2₹95Admitted-Finance	₹95	L2	Admitted-Finance
3	L3₹261.50Admitted-Finance	₹261.50	L3	Admitted-Finance

BoQ Comparative

Line Items (40)

Sl No	Description	Qty	Unit	Fresenius Kabi Oncology Limited L2	ADMAC LIFESCIENCES L3	Beta Drugs Limited L1
1.00	AZATHIOPRINE TAB IP 50 mg	1,06,631	1 No	-	-	-
2.00	CYCLOPHOSPHAMIDE TAB IP 50 mg	34,825	1 No	-	-	-
3.00	DACARBAZINE INJ IP/USP 200 mg	1,250	Vial	-	-	-
4.00	DACTINOMYCIN INJ 0.5 mg/3 ml	70	Vial	-	-	-
5.00	DAUNORUBICIN INJ IP 20 mg	642	Vial	-	230 ₹241.5	-
6.00	DEXAMETHASONE TAB IP 8 mg	1,27,416	1 No	-	-	-
7.00	DEXAMETHASONE TAB IP 4 mg	1,43,651	1 No	-	-	-
8.00	ENZALUTAMIDE CAP 80 mg	8,450	1 No	-	-	-
9.00	EXEMESTANE TAB IP 25 mg	7,945	1 No	-	-	-
10.00	FLUDARABINE PHOSPHATE INJ IP/ USP 50 mg	1	Vial	-	-	-

Corrigenda

Corrigendum

1 updatesLatest on 11 May 202611 May 202618 May 2026

Updated dates

Bid Submission End18 May 202611 May 2026

Bid Opening20 May 202613 May 2026

Download Ends18 May 202611 May 2026

Clarification Ends18 May 202611 May 2026

Tender Value

Refer Docs

EMD Value

₹50,000

Closing Date

18 May 2026, 5:00 pmClosed

Tender Inviting Organisation

Name

Managing Director

Address

KMSCL, THYCAUD

Work Description

Re-tender for the procurement Anti cancer drugs for the year 2026-27

Tender Information

Tender ID

2026_KMSCL_849143_1

Reference Number

KMSCL/ED/ACD/RT/2026/013

Tender Type

Open Tender

Product Category

Medicines

Period of Work

365 days

Location

Thiruvananthapuram

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer tender document

Documents Required

22 documents required · 22 mandatory

Fee/PreQual/Technical

RequiredCheck list in Anx 1 (.pdf)

RequiredDocumentary proof that the firm has claimed for exemption from submitting as per ls no 2 of Anx 1 (.pdf)

RequiredThe details of offline EMD submitted as per sl no 3 of Anx 1 (.pdf)

RequiredThe details of Re-inspection as per sl no 4 of Anx 1 (.pdf)

RequiredThe details of factory inspection fee as per sl no 5 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 6 of Anx 1 (.pdf)

RequiredBid offer form as per sl no 7 of Anx 1 (.xls)

RequiredNotary attested Average Annual turnover stmt as per sl no 8 of Anx 1 (.pdf)

RequiredNotary attested copies of manufacturing license as per sl no 9 of Anx 1 (.pdf)

RequiredNotary attested copies of valid import license as per sl no 10 of Anx1 (.pdf)

RequiredNotary attested copy of product wise market standing certificate as per sl no 11 of Anx 1 (.pdf)

RequiredNotary attested copy of valid license as per sl no 12 of Anx 1 (.pdf)

RequiredNotary attested copy of valid WHO-GMP certificate as per sl no 13 of Anx 1 (.pdf)

RequiredNotary attested copy of current Non conviction certificate as per sl no 14 of Anx1 (.pdf)

RequiredNotary attested performance stmt as per sl no 15 of Anx 1 (.pdf)

RequiredNotary attested copy of Power of Attorney as per sl no 16 of Anx 1 (.pdf)

RequiredNotary attested copy of Undertaking as per sl no 17 of Anx 1 (.pdf)

RequiredNotary attested copy of undertaking as per sl no 18 of Anx 1 (.pdf)

RequiredNotary attested copy of Audited Balance sheets and P and L stmt as per sl no 19 of Anx 1 (.pdf)

RequiredNotary attested details of technical personnel as per sl no 20 of Anx 1 (.pdf)

RequiredNotary attested details of the bidder as per Sl no 21 of Anx 1 (.pdf)

Finance

Requiredprice bid format (.xls)

Fee & Financial Details

Tender Fee Amount

₹29,500

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹50,000

EMD Fee Exemption Allowed

Yes

Important Dates

Last Activity

11 Jun 2026

Published

30 Apr 2026

Bid Opening

20 May 2026

Download Starts

30 Apr 2026

Download Ends

18 May 2026

Submission Starts

30 Apr 2026

Clarification Period

30 Apr 2026 - 18 May 2026

Bill of Quantities

Item WiseBoQ_Ver3.0INR

BoQ1 (40 items)

Sl No	Description	Qty	Unit	Est. Rate	Est. Amount
1	AZATHIOPRINE TAB IP 50 mg	1,06,631	1 No	5	₹5,33,155
2	CYCLOPHOSPHAMIDE TAB IP 50 mg	34,825	1 No	5	₹1,74,125
3	DACARBAZINE INJ IP/USP 200 mg	1,250	Vial	5	₹6,250
4	DACTINOMYCIN INJ 0.5 mg/3 ml	70	Vial	5	₹350
5	DAUNORUBICIN INJ IP 20 mg	642	Vial	5	₹3,210
6	DEXAMETHASONE TAB IP 8 mg	1,27,416	1 No	5	₹6,37,080
7	DEXAMETHASONE TAB IP 4 mg	1,43,651	1 No	5	₹7,18,255
8	ENZALUTAMIDE CAP 80 mg	8,450	1 No	5	₹42,250
9	EXEMESTANE TAB IP 25 mg	7,945	1 No	5	₹39,725
10	FLUDARABINE PHOSPHATE INJ IP/ USP 50 mg	1	Vial	5	₹5

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.03 MB

Technical Evaluation

tech_eval.pdf

PDF

Financial Bid Opening

boq_comp_chart.xlsx

xlsx

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.54 MB

Work Item Documents

BOQ_1434897.xls

BOQ • 0.34 MB

ACD.pdf

Tender Documents • 1.80 MB

Ready to Participate?

Download all tender documents and submit your bid